Cambridge, MA -- February, 28, 2023 -- hC Bioscience, a pioneer in the development of tRNA-based therapeutics, received an investment from CureDuchenne Ventures, the strategic investment arm of CureDuchenne, a global nonprofit committed to finding and funding a cure for Duchen...